Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study (Molecular Imaging and Biology, (2023), 25, 6, (1054-1062), 10.1007/s11307-023-01865-y)

Alice Petty*, Anna Garcia-Hidalgo, Els F. Halff, Sridhar Natesan, Dominic J. Withers, Elaine E. Irvine, Michelle Kokkinou, Lisa A. Wells, David R. Bonsall, Sac Pham Tang, Mattia Veronese, Oliver D. Howes

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original online version of this article was revised to add the following funding note: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101028661. The original article has been corrected.

Original languageEnglish
Pages (from-to)553
Number of pages1
JournalMolecular Imaging and Biology
Volume26
Issue number3
DOIs
Publication statusPublished - Jun 2024

Fingerprint

Dive into the research topics of 'Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study (Molecular Imaging and Biology, (2023), 25, 6, (1054-1062), 10.1007/s11307-023-01865-y)'. Together they form a unique fingerprint.

Cite this